Elevated Serum Total and LDL Cholesterol in Very Old Patients with Alzheimer’s Disease
- 9 February 2001
- journal article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 12 (2), 138-145
- https://doi.org/10.1159/000051248
Abstract
The relationships of serum lipids with Alzheimer’s disease (AD) and other dementias in very old patients are not clear. All residents of an academic nursing home were studied clinically for dementia and for serum lipids. All those autopsied over a 7.7-year period had apolipoprotein E (apoE) genotyping and detailed neuropathological examination. Those with pathologically defined criteria for AD (n = 84) were compared to all others who also had clinical dementia but did not show AD changes (n = 22). In contrast to most other reports of serum lipids in very old patients with AD, total cholesterol (TC) and low density lipoprotein cholesterol levels were each significantly higher for those with AD. The lipid-AD associations were progressively stronger with increasing pathological certainty of AD diagnosis. These relationships remained significant after adjustment for apoE genotype and for other known risk factors. The lipid-AD associations in a very old cohort, and prior evidence that elevated TC in middle life is a risk factor for later dementia, prompt consideration of factors associated with lipid metabolism in the development of Alzheimer’s dementia.Keywords
This publication has 20 references indexed in Scilit:
- Regional Distribution of Neuritic Plaques in the Nondemented Elderly and Subjects With Very Mild Alzheimer DiseaseArchives of Neurology, 1998
- Apolipoprotein E and the CNS Response to InjuryJournal of Cerebral Blood Flow & Metabolism, 1998
- Serum Total Cholesterol, Apolipoprotein E {FC12}e4 Allele, and Alzheimer’s DiseaseNeuroepidemiology, 1998
- Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older personsJAMA, 1997
- 15-year longitudinal study of blood pressure and dementiaThe Lancet, 1996
- The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging StudyPublished by American Medical Association (AMA) ,1995
- Neurodegeneration in the Central Nervous System of apoE-Deficient MiceExperimental Neurology, 1995
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993
- Apolipoprotein ∈4 homozygosity in young men with coronary heart diseaseThe Lancet, 1992
- Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob diseaseBrain Research, 1991